PT  - JOURNAL ARTICLE
AU  - Richard M. Carpiano
TI  - Demographic differences in US adult intentions to receive a potential coronavirus vaccine and implications for ongoing study
AID  - 10.1101/2020.09.07.20190058
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.07.20190058
4099  - http://medrxiv.org/content/early/2020/09/09/2020.09.07.20190058.short
4100  - http://medrxiv.org/content/early/2020/09/09/2020.09.07.20190058.full
AB  - Background The coronavirus pandemic’s public health and economic impacts have led to much hope in the US regarding the prospect of a safe, effective vaccine to either prevent infection or minimize symptoms and reduce mortality risk. However, recent US polls indicate a concerning level of hesitancy that will likely lead to suboptimal uptake if such a vaccine becomes available. This study investigated demographic differences regarding US adults’ intent, uncertainty, and refusal to receive a potential coronavirus vaccine and specific reasons for intention to receive it.Methods and findings Multivariable analysis of Associated Press (AP)-NORC Center for Public Affairs Research cross-sectional survey data collected in May 2020 from a US nationally representative panel of adults (n = 1000). Respondents were asked if they would receive a coronavirus vaccine (yes, unsure, no). Among those answering yes, the specific reasons were: to protect self, family, and community; chronic health condition; and having a doctor who recommends vaccines. Multinomial logistic regression models indicated numerous subgroup differences between participants who indicating (1) uncertainty versus refusal, (2) intent versus refusal, and (3) intent versus uncertainty, with the highest number of significant differences observed in the third comparison. Overall, higher likelihood of intention to receive the vaccine versus uncertainty and refusal were mostly observed among respondents with a college education or greater, White, non-Hispanic racial-ethnic identity, ages 60 or older, and more liberal (versus conservative) ideology. Despite variation in endorsement across the five reasons for wanting to receive the vaccine, subgroup differences were fairly consistent across these specific reasons when comparing respondents endorsing such intentions versus, respectively, refusal and uncertainty in separate analyses.Conclusions These findings suggest that the approval of a vaccine will potentially face problems with overall uptake due to uncertainty or refusal and contribute to creating significant demographic disparities in COVID-19 morbidity and mortality risk. Ongoing assessment of such attitudes are needed as Phase III trials proceed, but the findings highlight need for measuring uncertainty and its underlying reasons, as well as multiple types of education and outreach efforts for those who are uncertain as well as avoidant.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding supported the conduct of this paper.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Use of these data for this analysis was determined by the University of California, Riverside Institutional Review Board to be exempt from review.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data for this study are publicly available on the NORC website and were accessed by the study author via https://apnorc.org/projects/expectations-for-a-covid-19-vaccine/ https://apnorc.org/projects/expectations-for-a-covid-19-vaccine/ APAssociated PressFDAFood and Drug AdministrationRRRrelative risk ratioSESSocioeconomic status